Buckingham et al. Diabetes Technol Ther, 2009 [14] |
Prediction-based suspension |
CGM |
Simple linear regression in time, statistical models [15] |
30 |
80 |
90–90 |
Inpatient [14] |
Buckingham et al. Diabetes Care, 2010 [16] |
Prediction-based suspension |
CGM |
Voting schema of 5 separate prediction algorithms [17] |
35 |
80 |
30–90 |
Inpatient [16] |
Hughes et al. J Diabetes Sci Technol, 2010 [22] |
Detection-based attenuation |
CGM |
– |
– |
120 |
– |
In silico [22] |
Hughes et al. J Diabetes Sci Technol, 2010 [22] |
Prediction-based attenuation |
CGM, insulin |
Kalman filter with metabolic state observer |
15 |
120 |
– |
In silico [22] |
Patek et al. IEEE Trans Biomed Eng, 2012 [26] |
Prediction-based attenuation |
CGM, insulin |
Simple linear regression in time |
17 |
112.5 |
– |
In silico [26] |
Cameron et al. J Diabetes Sci Technol, 2012 [19] |
Prediction-based suspension |
CGM |
Kalman filter [18] |
70 |
80 |
0-120 |
Inpatient [19], outpatient [20] |
Buckingham et al. Diabetes Technol Ther, 2013 [20] |
Prediction-based suspension |
CGM |
Kalman filter [18] |
30 |
80 |
0–120 |
Outpatient [20, 38, 39, 46] |
Hughes et al. Comput Methods Programs Biomed, 2013 [25] |
Prediction-based attenuation |
CGM, insulin |
Simple linear regression in glucose with parameters from historical data |
30 |
120 or 140 |
– |
In silico [25] |
Stenerson et al. J Diabetes Sci Technol, 2014 [21] |
Prediction-based suspension |
CGM, accelerometer, heart rate |
Kalman filter [18] |
30 |
80 |
0–120 |
In silico [21] |